Do not use this product simultaneously with exposure to cholinesterase-inhibiting drugs, pesticides, or chemicals.
Adverse effects commonly seen are pain during injection and mild cholinergic signs such as salivation, nasal drip, or brief episodes of vomiting. Other effects seen less frequently are panting, restlessness, diarrhea, and mild injection site inflammation lasting one to several days. Rarely, injection site ulceration occurs, but the lesion is not resistant to healing.
If sever cholinergic signs occur, they may be reversed with atropine sulfate.
To report an adverse reaction, product-related problem, human exposure, or to obtain a copy of the Safety Data Sheet (SDS), please call Merck Animal Health Technical Services at 1-800-224-5318.
For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS or http://www.fda.gov/reportanimalae.